US EditionMouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males
The study reveals sex-specific brain patterns of GLP-1, with females showing higher density in appetite-control regions and males in olfactory areas, explaining drug efficacy differences.
3 Articles
3 Articles
Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes so thoroughly that the word "blockbuster" barely covers it. And yet, for all the billions of dollars spent, for all the prescriptions written, a fundamental question has lingered like a low hum beneath the clinical noise:…
New Sex-Specific Atlas of GLP-1 in Mouse Brain Sheds Light on Why Top
In a groundbreaking advance that promises to reshape our understanding of metabolic and psychiatric disorders, researchers at the Icahn School of Medicine at Mount Sinai have unveiled the first comprehensive sex-specific atlas mapping the distribution of glucagon-like peptide 1 (GLP-1) in the mouse brain at single-transcript resolution. This study, published on March 10, 2026, in […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
